How should investors evaluate CymaBay Therapeutics Inc. (NASDAQ:CBAY)?
Stocks of CymaBay Therapeutics Inc. (NASDAQ:CBAY) traded higher last session on Wall Street, up 8.19% to $16.24. According to the data, CymaBay Therapeutics Inc. (NASDAQ:CBAY) has 13 analysts covering its stock. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $33.00 and […]
Can CymaBay Therapeutics Inc. (CBAY) stock recover despite sales dropping?
The price of CymaBay Therapeutics Inc. (NASDAQ:CBAY) shares last traded on Wall Street fell -0.76% to $11.74. Based on available information, 11 analysts follow CymaBay Therapeutics Inc. (NASDAQ:CBAY). The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $19.00 and a low of […]
A secret that hides CymaBay Therapeutics Inc.’s strength (NASDAQ:CBAY)
Stocks of CymaBay Therapeutics Inc. (NASDAQ:CBAY) traded higher last session on Wall Street, up 5.21% to $11.52. According to the data, CymaBay Therapeutics Inc. (NASDAQ:CBAY) has 11 analysts covering its stock. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $19.00 and […]
